Abbonarsi

The value of patch testing patients with a scattered generalized distribution of dermatitis: Retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001 to 2004 - 24/04/13

Doi : 10.1016/j.jaad.2008.05.008 
Kathryn A. Zug, MD a, , Robert L. Rietschel, MD b, Erin M. Warshaw, MD, MS c, Donald V. Belsito, MD d, James S. Taylor, MD e, Howard I. Maibach, MD f, C.G. Toby Mathias, MD g, Joseph F. Fowler, MD h, James G. Marks, MD i, Vincent A. DeLeo, MD j, Melanie D. Pratt, MD k, Denis Sasseville, MD l, Frances J. Storrs, MD m
a Section of Dermatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 
b Section of Dermatology, University of Arizona Department of Veterans Affairs Health Care System, Tucson, Arizona 
c Dermatology Department, University of Minnesota and Veterans Affairs Medical Center, Minneapolis, Minnesota 
d University of Missouri, Kansas City, Missouri 
e Department of Dermatology, Cleveland Clinic, Cleveland, Ohio 
f Department of Dermatology, University of California San Francisco, San Francisco, California 
g Department of Dermatology, University of Cincinnati, Cincinnati, Ohio 
h University of Louisville, Louisville, Kentucky 
i Department of Dermatology, Pennsylvania State University, Hershey, Pennsylvania 
j Department of Dermatology, Columbia University, St Luke’s Roosevelt Hospital Center, New York, New York 
k Division of Dermatology, University of Ottawa, Ottawa, Ontario, Canada 
l Division of Dermatology, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada 
m Department of Dermatology, Oregon Health Science University, Portland, Oregon 

Correspondence to: Kathryn A. Zug, MD, Section of Dermatology, Dartmouth-Hitchcock Medical Center, One Medical Center Dr, Lebanon, NH 03755.

Abstract

Background

A scattered generalized distribution (SGD) of dermatitis is a challenging problem; patch testing is a strategy for evaluating allergic contact dermatitis as a relevant factor.

Objective

We sought to analyze patient characteristics and most frequently relevant positive allergens in patients presenting for patch testing with SGD.

Methods

We conducted retrospective cross-sectional analysis of North American Contact Dermatitis Group 2001 to 2004 data. Patients with SGD were compared with patients without SGD.

Results

Of 10,061 patients, 14.9% (n = 1497) had only a SGD. Men and patients with a history of atopic eczema were more likely to have dermatitis in a SGD (P < .001). Preservatives, fragrances, propylene glycol, cocamidopropyl betaine, ethyleneurea melamine formaldehyde, tixocortol pivalate, and budesonide were among the more frequently relevant positive allergens. Top allergen sources included cosmetics/beauty preparations/skin and health care products, clothing, and topical corticoids.

Limitations

This was a retrospective analysis of patch-tested patients with SGD suspected to have allergy.

Conclusions

A total of 49% of patients with SGD had at least one relevant positive allergen, thus demonstrating the benefit of patch testing these patients.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations used : NACDG, RPPT, SGD


Mappa


 Supported by the general research fund, Section of Dermatology, Dartmouth-Hitchcock Medical Center.
 Conflicts of interest: None declared.
 Presented at the Annual Meeting of the American Academy of Dermatology, Washington, DC, on February 1, 2007.
 Reprints not available from the authors.


© 2008  American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 59 - N° 3

P. 426-431 - settembre 2008 Ritorno al numero
Articolo precedente Articolo precedente
  • A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation
  • John C. Murray, James A. Burch, Robert D. Streilein, Mary Ann Iannacchione, Russell P. Hall, Sheldon R. Pinnell
| Articolo seguente Articolo seguente
  • Determinants of marginal traction alopecia in African girls and women
  • Nonhlanhla P. Khumalo, Susan Jessop, Freedom Gumedze, Rodney Ehrlich

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.